P Amat-Peral

Publications (2)0 Total impact

• Article: [Surgical removal of peripapillary choroidal neovascularization in young patients].

  J M Ruiz-Moreno, P Amat-Peral, F L Lugo, J A Montero
  [show abstract] [hide abstract]
  ABSTRACT: To analyze anatomical and visual outcomes after subretinal surgery for peripapillary choroidal neovascularization (CNV) not associated with age-related macular degeneration (AMD). Five eyes from five patients with peripapillary CNV who had been treated by subretinal surgery were retrospectively analyzed. The patients averaged 32 years of age (range, 11 to 49, SD 14.5 years) and mean follow-up was 31.4 months (range, 8 to 48, SD 20.8 months). Best corrected visual acuity was 0.05 (range, 0.001 to 0.16, SD 0.07) before surgery and 0.64 (range, 0.2 to 0.9, SD 0.26) after surgery (p=0.005; Student's t test for paired data). Neither intraoperative nor postoperative incidences occurred. Surgical removal may be considered one of the therapeutic options to treat peripapillary CNV not related to AMD.
  Archivos de la Sociedad Espanola de Oftalmologia 02/2009; 84(1):39-42.
• Article: [Photodynamic therapy with verteporfin in choroidal neovascularization after refractive surgery].

  P Amat-Peral, F Lugo, J A Montero, C de-la-Vega, J F Arévalo, J L Alió Y Sanz
  [show abstract] [hide abstract]
  ABSTRACT: To analyze the results obtained with Photodynamic Therapy (PDT) to treat subfoveal and juxtafoveal Choroidal Neovascularization (CNV) in patients with high myopia corrected by Laser-Assisted in situ Keratomileusis (LASIK) or by implanting a Phakic Intraocular Lens (PIOL). We analyzed the results from 14 highly myopic eyes corrected by LASIK (seven cases) or by PIOL implantation (seven cases), which later developed CNV and were treated by PDT with verteporfin. Mean Best Corrected Visual Acuity (BCVA) after refractive surgery was 0.45 SD 0.17 (range, 0.2 to 0.8), with residual spherical equivalent (RSE) -0.5 SD 1.8 D (range, 1 to 5.5 D). After CNV appearance, BCVA was 0.10 SD 0.19 (range, 0.025 to 0.7). CNV was treated in all cases by PDT (mean, 2.0 SD 0.8 treatments). After CNV closure, the mean BCVA improved up to 0.22 SD 0.18 (range, 0.1 to 0.63) (RSE -1.4 SD 1.4 D, range, 0.5 to -4 D). Differences in RSE after refractive surgery and after PDT, and differences between BCVA after CNV appearance and final were not statistically significant (p=0.82 and p=0.06, respectively, Student's t test paired data). We consider that PDT is effective in achieving closure of CNV in myopic patients after refractive surgery without inducing changes in spherical equivalent.
  Archivos de la Sociedad Espanola de Oftalmologia 10/2008; 83(9):539-44.